Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 534-544
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.534
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.534
Table 2 Risk factors for multidrug-resistant infection in cirrhosis
| No. | Risk factors for MDR infection in cirrhosis |
| 1 | Prior (3 mo) use of broad-spectrum antibiotics |
| 2 | Prior infection by MDROs (6 mo) |
| 3 | Nosocomial infection |
| 4 | Recent contact with the healthcare system |
| 5 | Site of infection (pneumonia, skin, and soft tissue infections) |
| 6 | Geographic region |
| 7 | Prophylactic use of antibiotics (?)/proton pump inhibitors use? |
- Citation: Terra C, de Mattos ÂZ, Chagas MS, Torres A, Wiltgen D, Souza BM, Perez RM. Impact of multidrug resistance on the management of bacterial infections in cirrhosis. World J Clin Cases 2023; 11(3): 534-544
- URL: https://www.wjgnet.com/2307-8960/full/v11/i3/534.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i3.534